Last reviewed · How we verify
Autologous Regulatory Т-cells — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Autologous Regulatory Т-cells (Autologous Regulatory Т-cells) — Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Autologous Regulatory Т-cells TARGET | Autologous Regulatory Т-cells | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Autologous Regulatory Т-cells CI watch — RSS
- Autologous Regulatory Т-cells CI watch — Atom
- Autologous Regulatory Т-cells CI watch — JSON
- Autologous Regulatory Т-cells alone — RSS
Cite this brief
Drug Landscape (2026). Autologous Regulatory Т-cells — Competitive Intelligence Brief. https://druglandscape.com/ci/autologous-regulatory-cells. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab